Idiopathic Pulmonary Fibrosis Clinical Trials
A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 113 clinical trials
Palliative Care Planner (PCplanner)
addressing needs and promoting advance care planning discussions among patients with idiopathic pulmonary fibrosis and their clinicians.
- 0 views
- 22 Apr, 2022
- 1 location
Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF
This study will evaluate the effect of CPAP therapy on esophageal pH and lung inflammation in patients with idiopathic pulmonary fibrosis (IPF) and sleep apnea.
- 0 views
- 12 May, 2022
- 1 location
The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease
Interstitial lung disease (ILD) is the result of over 200 etiological pathways arising from several different insults to the lung parenchyma: inhaled substances, drug side effects, connective tissue disease, infection, and malignancy. The disease can also be of idiopathic origin. If prolonged, the resulting inflammation causes permanent and progressive fibrotic …
- 81 views
- 14 Jun, 2022
- 3 locations
Controlled Investigation to Evaluate Impact of dCBT in Adult Subjects With IPF (COMPANION)
The purpose of the study is to assess efficacy and safety of a digital cognitive behavioural therapy for patients with idiopathic pulmonary fibrosis on anxiety and depression.
- 0 views
- 28 May, 2022
- 1 location
Assessment of Continuous Positive Airway Pressure Therapy in IPF (ACT-IPF)
idiopathic pulmonary fibrosis (IPF) and moderate-to-severe obstructive sleep apnea (OSA).
- 0 views
- 13 Apr, 2022
- 1 location
Letermovir for CMV Prevention After Lung Transplantation
transplant recipients (LTRs) with idiopathic pulmonary fibrosis (IPF).
- 0 views
- 27 May, 2022
- 1 location
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
expression in idiopathic pulmonary fibrosis (IPF), cirrhosis, and cardiac fibrosis.
- 0 views
- 25 Mar, 2022
- 1 location
Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia (PINCER)
The antifibrotic agents, namely pirfenidone and nintedanib have been found to be effective in the treatment of idiopathic pulmonary fibrosis (IPF). Nintedanib has also been found to be effective
- 38 views
- 11 May, 2022
- 1 location
Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis
have been developed and have demonstrated their ability to decrease pulmonary fibrogenic activity in diseases such as Idiopathic Pulmonary Fibrosis (IPF). This has been a milestone in the treatment of
- 0 views
- 25 Mar, 2022
The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled Trial
dyspnea symptoms assessed with the Six Minute Walking Test scale (6MWT). This test is validated for multiple pathologies, including idiopathic pulmonary fibrosis, the clinic of which could be comparable
- 0 views
- 22 Aug, 2021
- 1 location